cTTP
Informasjonen på denne siden er på engelsk.
The long-term burden of disease
Patients with cTTP experience disease- and treatment-related complications and burdens that have a negative impact on their HRQoL.
Artikkel
Unmet needs of cTTP patients
Prophylaxis is a recommended approach for some patients with congenital thrombotic thrombocytopenic purpura (cTTP)
Artikkel
Identifisering av cTTP-pasienter
The clinical presentation of cTTP ranges from life-threatening, acute, overt TTP events to milder TTP manifestations, including thrombocytopenia, haemolytic anaemia, abdominal pain, headaches and neurological symptoms.
Artikkel
Hva er de kliniske konsekvensene av cTTP?
The clinical presentation ranges from life-threatening, acute, overt TTP events to milder TTP manifestations, including thrombocytopenia, haemolytic anaemia, abdominal pain, headaches and neurological symptoms.
Artikkel
Hva forårsaker cTTP?
Congenital thrombotic thrombocytopenic purpura (cTTP) is caused by autosomal recessive mutations in the ADAMTS13 gene.
Artikkel
Hva er cTTP?
Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultra-rare thrombomicroangiopathy caused by an inherited deficiency of the VWF (von Willebrand Factor) cleaving metalloprotease, ADAMTS13, resulting in the abnormal presence of ultralarge VWF multimers and the formation of circulating platelet rich microthrombi.
Artikkel